Affymetrix

Affymetrix announces update regarding stock option grants

Published in Pharma Investments, Ventures and Law Weekly, September 24th, 2006

Affymetrix, Inc., (AFFX) announced it will request a hearing before the NASDAQ Listing Qualifications Panel in response to the receipt of a NASDAQ Staff Determination letter indicating that the company is not in compliance with the filing requirements for continued listing as set forth in Marketplace Rule 4310(c)(14).

As anticipated, the letter was issued in accordance with NASDAQ procedures due to the delayed filing of the company's Form 10-Q for the quarter ended June 30, 2006. Pending a decision by the panel, Affymetrix shares will remain listed on the NASDAQ Stock Market.

On August 9, 2006, the company announced that as a result of its previously...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly

Source: Pharma Investments, Ventures and Law Weekly (2006-09-24)

More Articles from Pharma Investments, Ventures and Law Weekly

4-Antibody
4-Antibody closes CHF 6 million series A financing, appoints Sijmen de Vries as CEO
Ablynx
Ablynx completes EUR 40 million series C financing
Adams Respiratory Therapeutics
Adams Respiratory Therapeutics reports 35% increase in net sales
Arrowhead Research
Arrowhead names Paul McDonnel as VP, finance and accounting
Arrowhead Research
Arrowhead raises additional capital from institutional shareholders
BaroFold
BaroFold appoints a new chief business officer
More from this issue of Pharma Investments, Ventures and Law Weekly

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry